Andrew Bellinger

Andrew Bellinger is the Chief Scientific Officer at Verve Therapeutics and the Co-Founder of Corner Therapeutics. Andrew also served as an Attending Cardiologist at Brigham and Women's Hospital. With a strong background in medicine, biochemistry, and physics, Andrew has held various leadership roles in pharmaceutical and clinical development, research, and scientific communication. Andrew co-founded and led R&D at Lyndra, and has extensive experience in building and inspiring teams, financing, and business development.